Robert Oliver
Director/Board Member at PSYBIO THERAPEUTICS CORP.
Net worth: 439 511 $ as of 2024-03-30
Profile
Robert Oliver is currently a Director at Exelixis, Inc., Neurotez, Inc., PsyBio Therapeutics Corp., Hyalo Technologies LLC, and a Member-Governors Board at Accreditation Council for Medical Affairs.
He was previously the President & Chief Executive Officer at Otsuka America Pharmaceutical, Inc., Chairman at Otsuka Canada Pharmaceutical, Inc., Vice President & Global Business Manager-Oncology at Wyeth Pharmaceuticals LLC, and Chief Executive Officer at V ClinBio LLC.
He also served as an Independent Director at Immunomedics, Inc. and Allarity Therapeutics, Inc. Mr. Oliver received his undergraduate degree from Rutgers State University of New Jersey and his MBA from Erivan K.
Haub School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXELIXIS, INC.
0.01% | 2023-05-30 | 18,176 ( 0.01% ) | 431 316 $ | 2024-03-30 |
PSYBIO THERAPEUTICS CORP
1.63% | 2023-01-04 | 1,365,800 ( 1.63% ) | 8 195 $ | 2024-03-30 |
Robert Oliver active positions
| Companies | Position | Start |
|---|---|---|
| PSYBIO THERAPEUTICS CORP. | Director/Board Member | 2021-04-20 |
| EXELIXIS, INC. | Director/Board Member | 2023-05-30 |
Neurotez, Inc.
 Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
| Hyalo Technologies LLC | Director/Board Member | - |
Former positions of Robert Oliver
| Companies | Position | End |
|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Director/Board Member | 2023-08-06 |
| IMMUNOMEDICS, INC. | Director/Board Member | 2017-02-15 |
| OTSUKA HOLDINGS CO., LTD. | Chief Executive Officer | 2016-12-31 |
V ClinBio LLC
 V ClinBio LLC BiotechnologyHealth Technology V ClinBio LLC operates as an biopharmaceutical company driving the development of novel drug products for treatment of immune and other related diseases. It develops New Molecular Entities using repurposing, incremental innovation and prodrug technology. The company was founded by Subbu Apparsundaram in 2013 and is headquartered in Newark, NJ. | Chief Executive Officer | - |
Otsuka Canada Pharmaceutical, Inc.
 Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The private company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Chairman | - |
Training of Robert Oliver
| Rutgers State University of New Jersey | Undergraduate Degree |
| Erivan K. Haub School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| OTSUKA HOLDINGS CO., LTD. | Health Technology |
| PSYBIO THERAPEUTICS CORP. | Health Technology |
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
Neurotez, Inc.
Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Health Technology |
Otsuka Canada Pharmaceutical, Inc.
Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The private company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Health Technology |
V ClinBio LLC
V ClinBio LLC BiotechnologyHealth Technology V ClinBio LLC operates as an biopharmaceutical company driving the development of novel drug products for treatment of immune and other related diseases. It develops New Molecular Entities using repurposing, incremental innovation and prodrug technology. The company was founded by Subbu Apparsundaram in 2013 and is headquartered in Newark, NJ. | Health Technology |
| Hyalo Technologies LLC |
- Stock Market
- Insiders
- Robert Oliver
